COMMUNIQUÉS West-GlobeNewswire

Ipsen réalise d’excellents résultats au premier semestre 2026 et relève ses objectifs financiers annuels
30/07/2026
Croissance semestrielle du chiffre d’affaires du Groupe de 23,5 % à taux de change constant 1 (20,4 % en données publiées), tirée par une croissance de 24,8 % des ventes du portefeuille de médicaments hors Somatuline [...]
Curium advances plans for second investment in Romania to expand access to advanced nuclear medicine
30/07/2026
Proposed expansion in the Cluj-Napoca region intended to strengthen PET imaging supply and support continued development of regional nuclear medicine services BOSTON, July 30, 2026 (GLOBE NEWSWIRE) -- Curium™ announced [...]
QUVIVIQ sales increased 62% year-on-year as Idorsia advances key drivers of future growth
30/07/2026
Ad hoc announcement pursuant to Art. 53 LR QUVIVIQ™ (daridorexant) sales reached CHF 91 million in H1 2026, up 62% year-on-year. Full-year 2026 guidance reaffirmed. Company focused on four key drivers of future growth. [...]
Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas
30/07/2026
Commercial Momentum Accelerates as Health System Adopts Turnkey Blood Volume Analysis via CLIA-Certified Send-Out Model OAK RIDGE, TN, July 29, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader [...]
Mesoblast Reports Ryoncil® Net Revenues of US$36M for the Quarter and US$115M for First Full Year of Product Launch
30/07/2026
Expanding indications for RYONCIL in children and adults with life-threatening inflammatory diseases Achieved target of at least 300 Patients treated in Pivotal Phase 3 trial for Chronic Low Back Pain Activity Report [...]
BRAVE Providers, LLC Launches The BRAVE Method, an Organizational Training Program Addressing Vicarious Trauma and Resilience in Trauma-Exposed Organizations
30/07/2026
Developed by trauma psychologist Jenny Hughes, PhD, the evidence-informed training gives groups, agencies, and organizations a shared framework for building vicarious resilience and retaining trauma clinicians. Houston [...]
Teladoc Health Reports Second Quarter 2026 Results
29/07/2026
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2026 (“Second Quarter 2026”). Unless [...]
Inventiva annonce ses résultats financiers préliminaires pour le premier semestre 2026¹
29/07/2026
Trésorerie et équivalents de trésorerie de 166,1 millions d'euros et 67,8 millions d'euros de dépôts à court terme 2 au 30 juin 2026 Daix (France), New York City (New York, États-Unis), le 29 juillet, 2026 – Inventiva ( [...]
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
29/07/2026
MALVERN, Pa., July 29, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
Onco360® Has Been Selected as a National Pharmacy Partner for VEPPANU™ (vepdegestrant)
29/07/2026
LOUISVILLE, Ky., July 29, 2026 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Rigel Pharmaceuticals for VEPPANU™ (vepdegestrant), which is [...]
Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results
29/07/2026
SEATTLE, July 29, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive [...]
Inventiva Announces Preliminary Financial Results for the First Half of 2026¹
29/07/2026
Cash and cash equivalents at €166.1 million and €67.8 million in short-term deposits 2 as at June 30, 2026 Daix (France), New York City (New York, United States), July 29, 2026 – Inventiva (Euronext Paris and NASDAQ: [...]
FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.
29/07/2026
Room-temperature-stable and rapidly reconstituted, this first FDA-licensed product brings new options to emergency and remote settings Silver Spring, MD, July 29, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug [...]
MIMEDX Announces Second Quarter 2026 Operating & Financial Results
29/07/2026
Reports Second Quarter Net Sales of $64 Million Reiterates Full Year Financial Outlook on a Standalone Basis Announces Plans to Acquire Sanara MedTech Management to Host Conference Call Today, July 29, 2026, at 4:30 PM [...]
DLH Reports Fiscal 2026 Third Quarter Results
29/07/2026
ATLANTA, July 29, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science [...]
Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
29/07/2026
- Biologics License Application (BLA) for z-rostudirsen in exon 51 DMD accepted for review by FDA; Priority Review granted; PDUFA target action date set for January 21, 2027 - - Completed enrollment of 71 participants [...]
VitalHub Announces Q2 2026 Conference Call Date
29/07/2026
TORONTO, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it will release financial results for the second quarter 2026 ended June 30, [...]
Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call
29/07/2026
DALLAS, July 29, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
29/07/2026
Data indicate that the 2026-2027 COVID-19 vaccine formula, targeting the XFG variant, induces a strong immune response against contemporary circulating and emerging lineages More than five billion doses of the Pfizer- [...]

Pages